Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,561
New position
Shares Held
116
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,269
of 1,348 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RMG Wealth Management LLC holds $1,240,336 across 9 Drug Manufacturers - General names. NVO ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,629 | $667,687 | |
| 2 | ABBV |
AbbVie Inc.
|
1,001 | $251,891 | |
| 3 | AMGN |
Amgen Inc
|
576 | $208,581 | |
| 4 | PFE |
Pfizer Inc
|
3,210 | $77,296 | |
| 5 | LLY |
ELI LILLY & Co
|
19 | $22,789 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
116 | $5,561 | |
| 7 | MRK |
Merck & Co., Inc.
|
42 | $5,397 | |
| 8 | BIIB |
Biogen Inc.
|
5 | $1,080 |
All Filings in NVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,561 | 116 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||